Pazopanib in Second-line Therapy in Renal Cell Carcinoma

NCT01577784 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Renal Cell Carcinoma

Interventions

DRUG: Pazopanib

Sponsor

Associació per a la Recerca Oncologica, Spain

Collaborators

[object Object]